logo_hcam

Revista Médica Científica CAMbios

Periodicidad semestral: flujo continuo.

ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)

Ver PDF (Spanish)

Keywords

Oxytocin
Cesarean Section
Uterine Contraction
Chest Pain
Hypotension
Nausea

How to Cite

1.
Oxytocin low-dosage use for handling uterine contraction in the transoperative of C-section patients of the Carlos Andrade Marin Hospital Obstetric Center. Cambios rev. méd. [Internet]. 2019 Jun. 27 [cited 2025 Nov. 21];14(25):23-6. Available from: https://revistahcam.iess.gob.ec/index.php/cambios/article/view/232

Abstract

Introduction: Oxytocin is the drug of choice for uterine contraction management, but its side effects are minimized. This study pretends to determine the frequency of side effects of high- dose oxytocin compared to low doses in the Obstetric Center of the Carlos Andrade Marin Hospital. Materials and methods: this is a descriptive study where 52 patients were studies and which were subjected to iterative caesarean study during the period may - june 2012. Results: high doses of oxytocin produce side effects such as chest pain (p less than 0.05), hypotension (p 0.002) and nausea (p 0.002). Three units of oxytocin do not modify the bleeding. Furthermore, surgeon satisfaction is 88.5%, similar to values reported worldwide. Conclusions: the use of low dosage of oxytocin for the management of uterine contractions during a cesarean section, showed no increase in bleeding (average of 463 ml), for which this dose may be considered a safe therapeutic dosage for the patient.

Ver PDF (Spanish)

References

Butwick A, Minimun effective bolus dose of oxytocin during elective caesarean delivery, BJA, Volume 104, Number 3, 3 march 2010

Dyer R.A, The Use of Uterotonic drugs during caesarean section, International Journal of Obstetric Anestesia, 2010

M.C. Svanstrom, et col, Signs of Myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergomatrine during Caesarean section

D Devikarani, Are we using right dose of oxytocin?, Indian J Anaesth, 2010 sep-oct; 54(5): 371-373

Frweis, Cardiovascular effects of oxytocin, Obstetric Gynecol, 1975 aug; 46(2): 211-4

Dean Leduc et co, Active Management of the third Stage of Labour: Prevention and Treatment of Pospartum Hemorrhage, JOGC, octubre, 2009

Palacio F.J. y col, Eficacia de la Oxitocina a dosis bajas en cesáreas electivas, Revista española de anestesiólogía y reanimación, vol. 58, 2011, págs. 6-10

Gregory A. L. Davies, Maternal Hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial, American College of Obstetricians and Gynecologists, 2005, vol. 105, no 2, february

Pinder AJ, Dresner M, Calow C, Shorten GD, O’Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 2002; 11: 156–9

Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br J Anaesth 2008; 101: 822–6

Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth 2007; 98: 116–9

Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin toprevent haemorrhage at caesarean section—a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2008; 37: 27–30

 

The authors who publish in this journal accept the following conditions:

1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.

2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.